JPH11279077A5 - - Google Patents

Info

Publication number
JPH11279077A5
JPH11279077A5 JP1998083695A JP8369598A JPH11279077A5 JP H11279077 A5 JPH11279077 A5 JP H11279077A5 JP 1998083695 A JP1998083695 A JP 1998083695A JP 8369598 A JP8369598 A JP 8369598A JP H11279077 A5 JPH11279077 A5 JP H11279077A5
Authority
JP
Japan
Prior art keywords
myositis
preventive
cells
active ingredient
therapeutic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998083695A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11279077A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP10083695A priority Critical patent/JPH11279077A/ja
Priority claimed from JP10083695A external-priority patent/JPH11279077A/ja
Publication of JPH11279077A publication Critical patent/JPH11279077A/ja
Publication of JPH11279077A5 publication Critical patent/JPH11279077A5/ja
Pending legal-status Critical Current

Links

JP10083695A 1998-03-30 1998-03-30 筋炎予防治療剤 Pending JPH11279077A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10083695A JPH11279077A (ja) 1998-03-30 1998-03-30 筋炎予防治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10083695A JPH11279077A (ja) 1998-03-30 1998-03-30 筋炎予防治療剤

Publications (2)

Publication Number Publication Date
JPH11279077A JPH11279077A (ja) 1999-10-12
JPH11279077A5 true JPH11279077A5 (enExample) 2005-10-06

Family

ID=13809641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10083695A Pending JPH11279077A (ja) 1998-03-30 1998-03-30 筋炎予防治療剤

Country Status (1)

Country Link
JP (1) JPH11279077A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002056531A (ja) 2000-08-14 2002-02-22 Ricoh Co Ltd 光ディスク情報記録方法および記録媒体

Similar Documents

Publication Publication Date Title
TR200200562T2 (tr) Vücutta kontrollü şekilde salgılanabilen ve nahoş tadı önleyebilen ağızdan alınmaya mahsus farmasötik bileşimler
BE2019C006I2 (enExample)
ES2159591T3 (es) Composicion de liberacion controlada.
CA2386690A1 (en) Pharmaceutical tramadol salts
JP2002511411A5 (enExample)
KR920019342A (ko) 골질환 치료제
DE69824632D1 (de) Purinderivate und medikamente, welche dieselben als aktiven bestandteil enthalten
BR9804500B1 (pt) derivado de amida, referida composição farmacêutica e agente terapêutico.
CA2257976A1 (en) Compositions and methods for coating medical devices
ES2192226T3 (es) Composicion farmaceutica oral que contiene agentes activos antimicrobianos y pantoprazol de liberacion prolongada.
DK1578406T3 (da) Farmaceutisk sammensætning med modificeret frigivelse
UY26372A1 (es) "imidazo-3-il-aminas bicíclicas procedimiento para su preparación y medicamentos que las contienen "
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
WO2005007137A8 (de) Ambroxolhaltige tabletten
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
ZA200007415B (en) Amino acid derivatives and drugs containing the same as the active ingredient.
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
TR199600421A2 (tr) Florfenil ikameli alkenil karbon asit-guanidid, bunlarin imalatina mahsus usul, bunlarin ilac ya da diagnoz maddesi olarak kullanilmalari ve bunlari ihtiva eden ilaclar.
NO985571L (no) Legemiddel for autoimmunsykdommer
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
WO2002053149A3 (de) Arzneimittel enthaltend ein polyamin als wirksubstanz
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
CA2091134A1 (en) Therapeutic agent for threatened abortion
JPH11279077A5 (enExample)